Characterization of the mechanism by which the RB/E2F pathway controls expression of the cancer genomic DNA deaminase APOBEC3B.

Journal: eLife

Published: 2020-09-28

DOI: 10.7554/elife.61287

Affiliations: 10

Authors: 12

Go to article
Institutions Share
NUS Cancer Science Institute of Singapore (CSI), Singapore 0.17
Department of Biochemistry, Molecular Biology, and Biophysics (BMBB), UMN, United States of America (USA) 0.15
Masonic Cancer Center, UMN, United States of America (USA) 0.15
Institute for Molecular Virology, UMN, United States of America (USA) 0.15
Department of Radiation Oncology, RU, Netherlands 0.10
NUS Yong Loo Lin School of Medicine (YLLSoM), Singapore 0.08
Cancer Institute, Erasmus MC, Netherlands 0.08
University of Minnesota (UMN), United States of America (USA) 0.06
Mater Research Institute - University of Queensland (MRI-UQ), Australia 0.02
Hennepin County Medical Center (HCMC), United States of America (USA) 0.02

Return

Except where otherwise noted © 2021 Springer Nature Limited. All Rights Reserved.
partner of AGORA, HINARI, OARE, INASP, ORCID, CrossRef and COUNTER